Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 October 2021 | Story Lunga Luthuli

Students and staff can now get vaccinated on all three campuses of the University of the Free State.

For the month of October, Clicks Pharmacy will be doing vaccinations ( Johnson and Johnson) on the Bloemfontein Campus for staff and students. Clicks Pharmacy staff will be available on the campus in EXR 1(enter from the basketball courts), next to the screening site, on Wednesdays from 09:00 to 13:00. 

The following should be noted: 
• The COVID-19 vaccine will be administered free of charge.
• You can speed up the process by registering on the COVID-19 Vaccination Programme registration portal before you get to the vaccination site. Staff will be on stand-by to register those who have not yet done so.  
• Please bring positive identification, such as an ID book or driver’s licence.
• You will receive proof of your first vaccination via a vaccine card.

In addition to the vaccination site at the Universitas Academic Hospital in Bloemfontein, staff and students can also get vaccinated on the Qwaqwa and South campuses. Take note that the Qwaqwa Campus vaccination site is open on Wednesdays only.


COVID-19 Vaccination Programme Registration link: https://vaccine.enroll.health.gov.za/#/ 

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept